Osteotec Re-Launches Silicone Finger Implant in the UK & Internationally

Osteotec has re-launched its Silicone Finger Implant in markets accepting CE-marked medical devices, following its European Medical Device Regulation (MDR) certification. 

“We are incredibly excited to reintroduce the Osteotec Silicone Finger Implant to both our UK and international customers,” said Anthony McClellan, Group General Manager of Osteotec. “… thanks to our dedicated teams and our strong partnerships with our notified body TÜV SÜD and the Compliant Medical Devices Ltd consultancy, we’ve been able to meet these regulatory requirements and continue offering a world-class solution for small joint arthroplasty.”

The Osteotec Silicone Finger Implant is a one-piece, sterile, flexible silicone elastomer implant that has been designed for arthroplasty of the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints. It offers a reliable solution for patients suffering from osteoarthritis, rheumatoid arthritis, or joint trauma.

“As a proud UK-based manufacturer, we have made a substantial investment to ensure the long-term availability of this essential product,” said Dean Stockwell, Sales and Marketing Director at Osteotec. “The Osteotec Silicone Finger Implant stands out as a British innovation that delivers tangible benefits to surgeons and patients alike. Our re-launch comes at a time when the regulatory environment has made it increasingly difficult for independent companies to thrive, but we remain committed to improving patient outcomes both in the UK and internationally.”

The Osteotec Silicone Finger Implant was launched in 2024 and has been widely used in hand surgery over the past two decades, delivering consistent, positive outcomes.

The Osteotec Silicone Finger Implant has remained available and widely used in FDA markets.